skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:033161/0797   Pages: 6
Recorded: 06/09/2014
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 3
1
Patent #:
Issue Dt:
07/07/2009
Application #:
10854405
Filing Dt:
05/26/2004
Publication #:
Pub Dt:
12/09/2004
Title:
CRYSTALLINE FORM OF BETA2 ADRENERGIC RECEPTOR AGONIST
2
Patent #:
NONE
Issue Dt:
Application #:
11654117
Filing Dt:
01/16/2007
Publication #:
Pub Dt:
07/05/2007
Title:
Crystalline form of beta2 adrenergic receptor agonist
3
Patent #:
Issue Dt:
08/10/2010
Application #:
12465350
Filing Dt:
05/13/2009
Publication #:
Pub Dt:
05/20/2010
Title:
CRYSTALLINE FORM OF A BETA2 ADRENERGIC RECEPTOR AGONIST
Assignor
1
Exec Dt:
06/01/2014
Assignee
1
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CALIFORNIA 94080
Correspondence name and address
JEFFREY HAGENAH
PATENT DEPARTMENT
THERAVANCE BIOPHARMA US, INC.
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CALIFORNIA 94080

Search Results as of: 05/29/2024 12:21 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT